Dexmedetomidine versus Fentanyl as an Additive to Propofol for Sedation in Elective Electrical Cardioversion

Dexmedetomidine versus Fentanyl as an Additive to Propofol for Sedation in Elective Electrical Cardioversion: Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202511757725214

Enrollment

100

Registered

2025-11-03

Start date

2025-10-20

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Dexmedetomidine

Fentanyl

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Age from 20 to 80 years. - Both sexes. - Patients scheduled for elective electrical cardioversion

Exclusion criteria

Exclusion criteria: - History of allergy or contraindication to any of the studied drugs. - Hemodynamically unstable patients. - Patients with a body mass index of more than 35 Kg/m2. - Patients American Society of Anesthesiologists III-IV classification. - Patients with low ejection fraction <40%.

Design outcomes

Primary

Measure	Time frame
Modified Ramsay Sedation Score (mRSS)	—

Secondary

Measure	Time frame
Total requirements of propofol ;Recovery time;Incidence of side effects;Heart rate;Mean Arterial Pressure;Oxygen saturation	—

Countries

Egypt

Contacts

Public ContactHasnaa Khafagy

Lecturer of Anaesthesia

hasnaa_gamal@med.kfs.edu.eg+201098830555

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026